Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit at Rs 1,691.2, representing a 5% gain from the previous close. This price band, set at 5%, capped the maximum daily gain allowed for the session. The upper circuit means trading effectively froze at this ceiling price, signalling that demand exceeded what the price band could accommodate. Buyers were willing to purchase shares at or above this level, but sellers were absent, creating unfilled demand that could potentially translate into further price pressure once the circuit unlocks. Venus Remedies Ltd is now just 2.79% shy of its 52-week high of Rs 1,736.9, underscoring the strength of the current rally.

Delivery and Volume Analysis

Volume on a circuit day is mechanically suppressed because the price lock reduces liquidity, which means demand likely exceeded what the traded volume reflects. On 9 Jun 2026, delivery volumes rose by 20.36% against the 5-day average, with 2.01 lakh shares taken in delivery. This increase in delivery volume is a strong signal of genuine buying conviction rather than speculative intraday trading. The total traded volume on 10 Jun was 1.29594 lakh shares, with a turnover of ₹21.27 crore, indicating that while the circuit limited price movement, the shares that did trade were largely absorbed by investors holding for the longer term. Venus Remedies Ltd's delivery data is the most revealing metric on a circuit day — does the rising delivery volume confirm sustained investor conviction or is it a temporary spike?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day lines. This alignment confirms a strong bullish trend that preceded the upper circuit event. The stock’s weighted average price was closer to the day’s low of Rs 1,571, suggesting that most volume was traded before the price surged to the circuit limit. The intraday range was relatively wide, from Rs 1,571 to Rs 1,691.2, indicating a recovery from an opening gap down of 2.46%. This intraday bounce culminating in a circuit lock highlights the resilience of the buying interest. is this breakout above all moving averages a sign of sustained momentum or a short-term spike?

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹2,117 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of around ₹1.04 crore based on 2% of the 5-day average traded value. While this liquidity is sufficient for retail and some institutional participation, it remains limited compared to larger caps. For micro-cap stocks, upper circuits carry a heightened liquidity risk — thin order books and limited trade sizes can amplify price moves and make entering or exiting positions challenging. The circuit lock at 5% gain is therefore significant but should be viewed with caution given the potential for volatility once normal trading resumes. with liquidity constraints in mind, how should investors approach micro-cap circuits like this?

Intraday Price Action

The stock opened lower at Rs 1,571, down 2.46% from the previous close, but recovered steadily throughout the session to touch the upper circuit at Rs 1,691.2. This intraday recovery of nearly 7.7% from the low to the circuit high demonstrates strong buying interest overcoming initial selling pressure. The narrow trading band near the circuit price towards the close reflects the price lock mechanism, where buyers were willing to transact at the ceiling but sellers remained absent. This pattern is typical for circuit hits and underscores the unfilled demand that remains in the market.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the stock is trading close to its 52-week high, the recent price action reflects market participants’ response to sector dynamics and company-specific developments. The micro-cap status means fundamentals can be overshadowed by liquidity and technical factors in the short term, but the sector’s overall growth trajectory remains a backdrop to the price movement.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at a 5% gain, combined with a 20.36% rise in delivery volumes and a position above all major moving averages, suggests that Venus Remedies Ltd is experiencing genuine buying interest rather than a speculative spike. However, the micro-cap nature and moderate liquidity profile mean that the price action is vulnerable to volatility once the circuit unlocks. The unfilled demand locked at the ceiling price indicates potential for further price movement, but investors should be mindful of the liquidity risk inherent in such stocks. after a 5% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Key Data at a Glance

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today